Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Baylor Medical Center at Garland
mi
from
Garland, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Baylor Medical Center at Garland
mi
from
Garland, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Breast Care Center at Baylor College of Medicine/Methodist Hospital
mi
from
Houston, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Breast Care Center at Baylor College of Medicine/Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
The University of Texas M. D. Anderson Cancer Center
mi
from
Houston, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
The University of Texas M. D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Joe Arrington Cancer Research and Treatment Center
mi
from
Lubbock, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Joe Arrington Cancer Research and Treatment Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Southwest Cancer Center
mi
from
Lubbock, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Southwest Cancer Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Baylor Regional Medical Center
mi
from
Plano, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Baylor Regional Medical Center
mi
from
Plano, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Scott & White Hospital
mi
from
Temple, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Scott & White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Danville Hematology & Oncology
mi
from
Danville, VA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Danville Hematology & Oncology
mi
from
Danville, VA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Olympic Hematology and Oncology Associates
mi
from
Bremerton, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Olympic Hematology and Oncology Associates
mi
from
Bremerton, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Benaroya Research Institute at Virginia Mason
mi
from
Seattle, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Benaroya Research Institute at Virginia Mason
mi
from
Seattle, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Yakima Valley Memorial Hospital North Star Lodge Cancer Center
mi
from
Yakima, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Yakima Valley Memorial Hospital North Star Lodge Cancer Center
mi
from
Yakima, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Marshfield Clinic
mi
from
Marshfield, WI
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Tom Baker Cancer Centre
mi
from
Calgary,
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Tom Baker Cancer Centre
mi
from
Calgary,
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Metro-Minnesota
mi
from
Saint Louis Park, MN
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Alvin J Siteman Cancer Center at Barnes-Jewish Hosp & Washington U Sch of Med
mi
from
Saint Louis, MO
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Alvin J Siteman Cancer Center at Barnes-Jewish Hosp & Washington U Sch of Med
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Missouri Baptist Medical Center
mi
from
Saint Louis, MO
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Missouri Baptist Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Wilford Hall Medical Center
mi
from
Lackland Air Force Base, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Wilford Hall Medical Center
mi
from
Lackland Air Force Base, TX
Click here to add this to my saved trials
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Varying Risk Factors for Alzheimer's Disease and Subjects on a Ketogenic Diet
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Varying Risk Factors for Alzheimer's Disease and Subjects on a Ketogenic Diet
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study
Feasibility of Extended Post-Acute Intervention for Hip Fracture Patients With Cognitive Limitations: Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study (HipERS)
Status: Enrolling
Updated:  12/31/1969
University of Maryland
mi
from
Baltimore, MD
Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study
Feasibility of Extended Post-Acute Intervention for Hip Fracture Patients With Cognitive Limitations: Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study (HipERS)
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Intervention to Reduce Sedentary Time
Intervention to Reduce Sitting Time in Mild Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Intervention to Reduce Sedentary Time
Intervention to Reduce Sitting Time in Mild Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
COcoa Supplement and Multivitamin Outcomes Study for the Mind
COcoa Supplement and Multivitamin Outcomes Study-Mind
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
COcoa Supplement and Multivitamin Outcomes Study for the Mind
COcoa Supplement and Multivitamin Outcomes Study-Mind
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Alliance for Wellness dba Alliance for Research
mi
from
Long Beach, CA
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Alliance for Wellness dba Alliance for Research
mi
from
Long Beach, CA
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
IPS Research Company
mi
from
Oklahoma City, OK
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Road Runner Research
mi
from
San Antonio, TX
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Aspen Clinical Research, LLC
mi
from
Orem, UT
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
Brickstone/Saint John Meadow
mi
from
Rochester, NY
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
Brickstone/Saint John Meadow
mi
from
Rochester, NY
Click here to add this to my saved trials
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
River Edge Manor
mi
from
Rochester, NY
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
River Edge Manor
mi
from
Rochester, NY
Click here to add this to my saved trials
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Status: Enrolling
Updated:  12/31/1969
UCSD Sleep Lab
mi
from
San Diego, CA
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Status: Enrolling
Updated: 12/31/1969
UCSD Sleep Lab
mi
from
San Diego, CA
Click here to add this to my saved trials
Intervention Comparative Effectiveness for Adult Cognitive Training
Intervention Comparative Effectiveness for Adult Cognitive Training
Status: Enrolling
Updated:  12/31/1969
Florida State University
mi
from
Tallahassee, FL
Intervention Comparative Effectiveness for Adult Cognitive Training
Intervention Comparative Effectiveness for Adult Cognitive Training
Status: Enrolling
Updated: 12/31/1969
Florida State University
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Prevention of Early Postoperative Decline
Prevention of Early Postoperative Decline
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Prevention of Early Postoperative Decline
Prevention of Early Postoperative Decline
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
UNC Chapel Hill Program on Integrative Medicine
mi
from
Chapel Hill, NC
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
UNC Chapel Hill Program on Integrative Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Administration Method of Cognitive Screening in Older Individuals With Hearing Loss
The Impact of Test Administration Method on Cognitive Screening Results in Older Individuals With Hearing Loss
Status: Enrolling
Updated:  12/31/1969
Hearing Aid Laboratory
mi
from
Evanston, IL
Administration Method of Cognitive Screening in Older Individuals With Hearing Loss
The Impact of Test Administration Method on Cognitive Screening Results in Older Individuals With Hearing Loss
Status: Enrolling
Updated: 12/31/1969
Hearing Aid Laboratory
mi
from
Evanston, IL
Click here to add this to my saved trials
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Community Physicians
mi
from
Aberdeen, MD
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Community Physicians
mi
from
Aberdeen, MD
Click here to add this to my saved trials
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated:  12/31/1969
Medstar Center for Successful Aging
mi
from
Baltimore, MD
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated: 12/31/1969
Medstar Center for Successful Aging
mi
from
Baltimore, MD
Click here to add this to my saved trials
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Community Physicians
mi
from
Westminster, MD
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Community Physicians
mi
from
Westminster, MD
Click here to add this to my saved trials
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Status: Enrolling
Updated:  12/31/1969
Regions Hospital
mi
from
Saint Paul, MN
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Status: Enrolling
Updated: 12/31/1969
Regions Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Rush University
mi
from
Chicago, IL
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Harvard School of Public Health
mi
from
Boston, MA
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Harvard School of Public Health
mi
from
Boston, MA
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
US Army, Fort Benning
mi
from
Fort Benning, GA
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
US Army, Fort Benning
mi
from
Fort Benning, GA
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health
mi
from
Bethesda, MD
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials